Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of ovalbumin in preparing medicines for preventing and/or treating jaundice

An ovalbumin and drug technology, applied in the field of medicine, can solve problems such as ovalbumin that have not yet been seen, and achieve the effects of reducing the level of serum total bilirubin, improving the effect of jaundice, alleviating treatment pain and economic burden

Inactive Publication Date: 2017-11-21
芦达
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main way to utilize ovalbumin is to eat it as a nutrient, and there are no related reports on the use of ovalbumin to prevent and treat jaundice

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ovalbumin in preparing medicines for preventing and/or treating jaundice

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Clinical observation of ovalbumin in the treatment of neonatal jaundice

[0024] From November 2014 to the present for one and a half years, a total of 69 cases of neonatal jaundice have been treated.

[0025] Diagnostic criteria: Neonatal jaundice index (serum total bilirubin level) standard refers to the "Expert Consensus on Diagnosis and Treatment of Neonatal Hyperbilirubinemia" (Neonatal Group, Pediatric Branch of Chinese Medical Association. "Chinese Journal of Pediatrics" 2014 2010, Vol. 52, No. 10), hyperbilirubinemia is defined when the bilirubin level exceeds the 95th percentile of the neonatal hourly bilirubin nomogram, see figure 1 . Of the 69 cases, 6 were in the high-risk zone (hyperbilirubinemia), 15 were in the intermediate-high-risk zone, 12 were in the intermediate-low-risk zone, and 33 were in the low-risk zone.

[0026] Clinical symptoms: light yellow jaundice is limited to the face and neck, or spreads to the trunk, and the sclera can als...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of ovalbumin in preparing medicines for preventing and / or treating jaundice. Based upon curative effect results in the clinical field, the ovalbumin provided by the invention can take an excellent jaundice removing effect, and the ovalbumin, as being applied for 3-9 days, can effectively reduce a serum total bilirubin level in patients with the jaundice. In comparison with existing conventional treatment means in the clinical field, the invention, which adopts the ovalbumin to treat the jaundice, is good in curative effect, short in treatment cycle and low in cost of medicinal raw materials; treatment pain and economic burdens of the patients can be greatly reduced; and the ovalbumin has a broad prospect of clinical application.

Description

technical field [0001] The invention relates to the use of ovalbumin in the preparation of a medicine for treating and / or preventing jaundice, and belongs to the field of medicine. Background technique [0002] The occurrence of jaundice is caused by the increase of serum bilirubin concentration due to bilirubin metabolism disorder. Clinically, the sclera, mucous membrane, skin and other tissues are stained yellow. When the jaundice deepens, urine, sputum, tears and Sweat is also stained yellow; in addition, it is often accompanied by gastrointestinal symptoms such as bloating, abdominal pain, loss of appetite, nausea, vomiting, diarrhea or constipation. [0003] Modern medical research has shown that the pathogenesis of jaundice includes excessive bilirubin production, low function of liver cells or reduced amount of functional liver cells, destruction of liver cells combined with bilirubin spillage, etc. The etiology of jaundice is complex and difficult to treat clinically...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/38A61P1/16
CPCA61K9/0014A61K38/38
Inventor 芦达
Owner 芦达
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com